Canada's Profound Medical Q2 loss shrinks on lower costs, revenue hit by shipment timing
Canada's Profound Medical Q2 loss shrinks on lower costs, revenue hit by shipment timing
Overview
Canada medical device firm's Q2 revenue rose 12% yr/yr but missed analyst expectations
Q2 operating expenses fell 16%, driving a 39% improvement in net loss
Company reiterates 2026 revenue guidance, citing strong order and reimbursement momentum
Outlook
Company reiterates full-year 2026 revenue guidance of approximately $25.0 mln
Company expects full-year 2026 gross margin to be 70% or higher
Company cites record order activity and expanded commercial pipeline as supporting outlook
Result Drivers
SHIPMENT TIMING - Co said Q2 revenue was reduced by $3.1 mln in TULSA shipments recognized in Q3 due to logistics, not demand
OPERATING COST REDUCTIONS - Operating expenses fell 16% yr/yr, mainly due to lower personnel, commercial, travel, insurance, and clinical trial costs
GROSS MARGIN EXPANSION - Gross margin rose to 78% from 73% on favorable product mix, including capital system sales previously under operating leases
Company press release: ID:nGNX4FK7T9
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $2.50 mln | $5.50 mln (4 Analysts) |
Q2 Loss Per Share |
| $0.26 |
|
Q2 Net Loss |
| $9.5 mln |
|
Q2 Operating Expenses |
| $13 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Reuters Recommended Reads
Aug 3 - ClearPoint Neuro Q2 revenue rises 18% but misses estimates
Aug 6 - Teleflex Q2 revenue rises 29%, beats analyst estimates
Aug 6 - Becton Dickinson Q3 revenue beats on product launches
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)